Federal contract award

75F40121F19014

EXPLORING INTRAVENOUS INJECTION BEHAVIORS KNOWLEDGE AND DRUG PREFERENCES OF INDIVIDUALS INJECTING PRESCRIPTION OPIOIDS OR PRESCRIPTION STIMULANTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541611 — Administrative Management and General Management Consulting Services
PSCB599 — Other Special Studies and Analysis
Parent award / vehicle75F40120A00017
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$886.8K
Current contract value$886.8K
Potential contract value / ceiling$886.8K
Start dateAug 25, 2021
Current end dateAug 29, 2025
Potential end dateSep 30, 2025
Latest award activityOct 27, 2025
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Oct 27, 2025P00008$-6.7KEXPLORING INTRAVENOUS INJECTION BEHAVIORS KNOWLEDGE AND DRUG PREFERENCES OF INDIVIDUALS INJECTING PRESCRIPTION OPIOIDS OR PRESCRIPTION STIMULANTS. -THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
Aug 29, 2025P00007$0EXPLORING INTRAVENOUS INJECTION BEHAVIORS KNOWLEDGE AND DRUG PREFERENCES OF INDIVIDUALS INJECTING PRESCRIPTION OPIOIDS OR PRESCRIPTION STIMULANTS
Mar 25, 2025P00006$0EXPLORING INTRAVENOUS INJECTION BEHAVIORS KNOWLEDGE AND DRUG PREFERENCES OF INDIVIDUALS INJECTING PRESCRIPTION OPIOIDS OR PRESCRIPTION STIMULANTS
Dec 3, 2024P00005$0EXPLORING INTRAVENOUS INJECTION BEHAVIORS KNOWLEDGE AND DRUG PREFERENCES OF INDIVIDUALS INJECTING PRESCRIPTION OPIOIDS OR PRESCRIPTION STIMULANTS

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.